Impact of comorbidities on oncological outcomes of Japanese patients with high grade soft tissue sarcomas
Autor: | Takashi Tajima, Toru Udaka, Naobumi Hosogane, Shoichi Ichimura, Takeshi Morii |
---|---|
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment MEDLINE Soft Tissue Neoplasms Comorbidity 03 medical and health sciences 0302 clinical medicine Japan Internal medicine mental disorders Humans Medicine Orthopedics and Sports Medicine Significant risk Aged Retrospective Studies 030222 orthopedics business.industry Incidence (epidemiology) Soft tissue sarcoma Soft tissue Sarcoma Prognosis medicine.disease Radiation therapy Charlson comorbidity index Surgery Neoplasm Recurrence Local business 030217 neurology & neurosurgery |
Zdroj: | Journal of Orthopaedic Science. 26:878-884 |
ISSN: | 0949-2658 |
Popis: | Considering the invasiveness of standard multidisciplinary approaches used for the treatment of soft tissue sarcoma, including surgery with wide margins, intensive chemotherapy, and radiotherapy, evaluation of comorbidities in high-grade soft tissue sarcoma patients is essential. Several previous studies have reported the impact of comorbidities on the survival of soft tissue sarcoma patients. Patient health status differs between nationalities or ethnic groups and only limited data has been reported with respect to the impact of comorbidities on Japanese soft tissue sarcoma patients.The incidence of each comorbidity, relationship between comorbidities and underlying clinicopathological factors, relationship between treatment status and comorbidities, and impact of comorbidities on disease-specific death in 136 patients with high-grade soft tissue sarcoma at the authors' institution were analyzed. For the evaluation of comorbidities, the updated Charlson comorbidity index was applied.Of the patients, 25% presented with more than one comorbidity. Elderly patients showed a significantly higher incidence of comorbidities (p 0.0001). Patients with congestive heart failure (p = 0.004), dementia (p 0.0001), hemiplegia/paraplegia (p 0.0001), and renal disease (p 0.0001) showed worse prognosis. Tumor grade (p = 0.01) and updated Charlson comorbidity index (p 0.0001) were independent risk factors for disease-specific death.Comorbidity status was a significant risk factor for disease-specific death in Japanese patients with high-grade soft tissue sarcoma. Innovations in comorbidity management may be a means for the improvement of oncological outcomes in soft tissue sarcoma. Given the difficulties in conducting standard randomized control studies in this field, data accumulation from real-world cases appears to be the most practical approach in establishing and applying strategies for the treatment of patients with comorbidities or elderly patients. |
Databáze: | OpenAIRE |
Externí odkaz: |